Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Antenatal
  - AverageAgeOfOnset:
      value: Infancy
  - AverageAgeOfOnset:
      value: Neonatal
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377789
    value: Malformation syndrome
  Label: Propylthiouracil embryofetopathy
  ORPHAcode: '485358'
  ORPHApacketId: '485358'
  PURL: http://www.orpha.net/ORDO/Orphanet_485358
  Parents:
  - Parent:
    - Label: Teratogenic Pierre Robin syndrome
      ORPHAcode: '138059'
  - Parent:
    - Label: Toxic or drug-related embryofetopathy
      ORPHAcode: '251529'
  Prevalences:
    Prevalence:
    - PrevalenceClass: Unknown
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET_25974033[PMID]
      ValMoy: '0.0'
  Synonyms:
  - Synonym: PTU embryofetopathy
  - Synonym: PTU embryopathy
  - Synonym: Propylthiouracil embryopathy
  TextSection:
    Contents: Propylthiouracil embryofetopathy is a rare teratologic disease characterized
      by variable congenital anomalies resulting from maternal treatment and prenatal
      exposure to propylthiouracil. Anomalies frequently encountered include ear malformations
      (e.g. accessory auricle preauricular sinus/fistula/cyst) urinary system malformations
      (e.g. isolated unilateral kidney congenital hydronephrosis) gastrointestinal
      anomalies (e.g. congenital bands with intestinal malrotation) and cardiac defects
      (e.g. situs inversus dextrocardia cardiac outflow tract defects).
    TextSectionType: Definition
  copyright: Orphanet (c) 2024
  creationDate: '2024-07-01 09:48:26'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
